Search
Menu

Goal and Learning Outcomes

The goal of this osteoporosis continuing education program is to provide nurses with information and evidence about the latest options in alternative therapies for the prevention and treatment of postmenopausal osteoporosis. After studying the information presented here, you will be able to:
  • Describe alternative therapies for the prevention and treatment of osteoporosis
  • Describe alternative therapies for the prevention and treatment of osteoporotic fractures
  • Explain the role of the healthcare professional in educating patients about alternative therapies in osteoporosis prevention, care, and management
 
Please note: The Orthopaedic Nurses Certification Board has designated this educational activity to receive 1.0 contact hour in Category A and 0 contact hours in Category B toward recertification.
 

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.